Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.
In Vivo. 2021 Sep-Oct;35(5):2793-2800. doi: 10.21873/invivo.12565.
In Vivo. 2021.
PMID: 34410970
Free PMC article.
GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.
Sugiyama Y, Naiki T, Tasaki Y, Mimura Y, Etani T, Noda Y, Nozaki S, Shimizu N, Banno R, Nagai T, Isobe T, Ando R, Moritoki Y, Kataoka T, Odagiri K, Aoki M, Gonda M, Yasui T, Hibi Y.
Sugiyama Y, et al. Among authors: banno r.
Oncology. 2023;101(4):224-233. doi: 10.1159/000529203. Epub 2023 Jan 23.
Oncology. 2023.
PMID: 36689919
Item in Clipboard
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.
Isobe T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Nozaki S, Iida K, Noda Y, Shimizu N, Tomiyama N, Banno R, Kubota H, Hamamoto S, Ando R, Kawai N, Yasui T.
Isobe T, et al. Among authors: banno r.
Int J Clin Oncol. 2022 Jan;27(1):165-174. doi: 10.1007/s10147-021-02046-z. Epub 2021 Oct 11.
Int J Clin Oncol. 2022.
PMID: 34633579
Item in Clipboard
Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
Etani T, Naiki T, Sugiyama Y, Nagai T, Iida K, Noda Y, Shimizu N, Tasaki Y, Mimura Y, Okada T, Banno R, Kubota H, Hamamoto S, Ando R, Kawai N, Yasui T.
Etani T, et al. Among authors: banno r.
Oncology. 2020;98(12):876-883. doi: 10.1159/000508923. Epub 2020 Aug 28.
Oncology. 2020.
PMID: 32862183
Item in Clipboard
C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.
Morikawa T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Isobe T, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Yasui T.
Morikawa T, et al. Among authors: banno r.
Cancers (Basel). 2024 Apr 28;16(9):1725. doi: 10.3390/cancers16091725.
Cancers (Basel). 2024.
PMID: 38730675
Free PMC article.
Item in Clipboard
Complete response of renal cell carcinoma with an inferior vena cava tumor thrombus and lung metastases after treatment with nivolumab plus ipilimumab.
Okada T, Hamamoto S, Etani T, Naiki T, Sue Y, Banno R, Yamada K, Sakakura T, Yasui T.
Okada T, et al. Among authors: banno r.
Int Cancer Conf J. 2020 Mar 13;9(2):88-91. doi: 10.1007/s13691-020-00403-9. eCollection 2020 Apr.
Int Cancer Conf J. 2020.
PMID: 32257760
Free PMC article.
Item in Clipboard
Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis.
Naiki T, Iida K, Etani T, Nagai T, Tanaka Y, Sugiyama Y, Ando R, Hamamoto S, Banno R, Nagata D, Kawai N, Yasui T.
Naiki T, et al. Among authors: banno r.
Cancer Manag Res. 2018 Sep 18;10:3669-3677. doi: 10.2147/CMAR.S172913. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 30271215
Free PMC article.
Item in Clipboard
Cite
Cite